Effects of KT and Scapular Stabilization Exercises.

Launched by SEHAT MEDICAL COMPLEX · Nov 13, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating two different treatments for a condition called subacromial impingement syndrome, which causes shoulder pain due to the narrowing of space around the shoulder joint. The study aims to compare the effects of Kinesiotaping, which involves applying special tape to support the shoulder, against scapular stabilization exercises, which strengthen the muscles around the shoulder blade. Both treatments are commonly used, but this trial will help determine which is more effective in relieving pain and improving movement.

If you're between the ages of 18 to 55 and have experienced pain on the front and side of your shoulder for at least three months, you might be eligible to participate. Participants will undergo either the Kinesiotaping or the scapular exercises and will be monitored for their progress. However, if you have certain shoulder conditions or have had recent surgery or injury, you may not qualify. This study is currently recruiting participants at the Punjab Sports Board in Lahore, and it could provide valuable insights into managing shoulder pain effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants with age between 18 to 55 years. Participants with pain on the anterolateral side of the shoulder for ≥3 months. Participants diagnosed with ≥3 positive clinical signs of SIS, such as the Neer or Hawkins-Kennedy test, a painful arc by a sports physical therapist.
• • Mild or Moderate pain on resisted external rotation, or the Empty Can test.
• Exclusion Criteria:
• • Diagnosis of cervical radiculopathy. Participants with osteoarthritis in the acromioclavicular or glenohumeral joint.
• • Calcific tendinitis, adhesive capsulitis, glenohumeral instability or a partial or full-thickness rotator cuff tear, clinical history of acute trauma, previous surgery or previous fracture in the affected shoulder. Corticosteroid injection into the shoulder joint in the previous 12 months.